ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,898.19
-0.32%
US Tech 100
20,066.80
-0.30%
Dow Jones
43,511.96
0.24%
Brent Oil
73.475
0.87%
Bitcoin
96,465.78
2.23%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Pulmonx Corporation (LUNG) Quote

Pulmonx Corporation

Pulmonx Corporation (LUNG)

NASDAQ
6.24
0.04
( 0.65% )
Updated: 10:21:43
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
6.24
Bid
6.24
Ask
6.27
Volume
30,688
6.12 Day's Range 6.5799
5.46 52 Week Range 14.92
Market Cap
246.404M
Previous Close
6.20
Open
6.26
Last Trade
396
@
6.24
Last Trade Time
10:21:43
Financial Volume
$ 191,428
VWAP
6.2379
Average Volume (3m)
229,996
Shares Outstanding
39,487,879
Dividend Yield
-
PE Ratio
-4.06
Earnings Per Share (EPS)
-1.54
Revenue
68.68M
Net Profit
-60.84M

About Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). the company's solutions comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment ... Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). the company's solutions comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the U.S. and international markets. Show more

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Website
www.pulmonx.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Pulmonx Corporation is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker LUNG. The last closing price for Pulmonx was $6.20. Over the last year, Pulmonx shares have traded in a share price range of $ 5.46 to $ 14.92.

Pulmonx currently has 39,487,879 shares outstanding. The market capitalization of Pulmonx is $244.82 million. Pulmonx has a price to earnings ratio (PE ratio) of -4.06.

Ask ADVFN Intelligence (AI)

LUNG Latest News

More News

Pulmonx to Present at the Piper Sandler 36th Annual Healthcare Conference

REDWOOD CITY, Calif., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced...

19 hours ago
GlobeNewswire Inc.

Pulmonx Partners with American Lung Association to Launch New Educational Initiatives for COPD Patients and Providers

Two New Programs Aim to Improve Awareness and Support for Patients with Severe COPD/Emphysema Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for...

November 19 2024
Business Wire

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

November 14 2024
Edgar (US Regulatory)

Pulmonx to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

REDWOOD CITY, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced...

November 07 2024
GlobeNewswire Inc.

Pulmonx to Present at the Stifel 2024 Healthcare Conference

REDWOOD CITY, Calif., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced...

November 05 2024
GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

November 01 2024
Edgar (US Regulatory)

Form 8-K - Current report

October 30 2024
Edgar (US Regulatory)

Pulmonx Reports Third Quarter 2024 Financial Results

REDWOOD CITY, Calif., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today...

October 30 2024
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

October 21 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

October 17 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.5725-8.403669724776.81256.81255.841819346.24457664CS
40.040.6451612903236.27.825.842296036.73562364CS
12-1.27-16.91078561927.518.795.842299967.20065474CS
26-2.65-29.80877390338.899.145.462998926.94489817CS
52-4.45-41.627689429410.6914.925.463754598.93199195CS
156-28.44-82.006920415234.6836.374.0740037813.43156669CS
260-31.76-83.57894736843869.47794.0738040620.94287903CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
WORXSCWorx Corporation
$ 2.235
(128.06%)
86.61M
SKKSKK Holdings Limited
$ 9.42
(106.58%)
3.18M
CRNCCerence Inc
$ 5.0582
(79.37%)
12.46M
SPAISafe Pro Group Inc
$ 4.41
(37.81%)
35.54M
CDTConduit Pharmaceuticals Inc
$ 0.1236
(33.91%)
425.15M
PYXSPyxis Oncology Inc
$ 2.0684
(-45.85%)
7.03M
KURAKura Oncology Inc
$ 10.0068
(-37.10%)
5.74M
SHOTWSafety Shot Inc
$ 0.1001
(-33.27%)
2.5k
AGFYAgrify Corporation
$ 25.95
(-33.05%)
295.62k
BLRXBioLineRx Ltd
$ 0.3717
(-31.82%)
4.77M
CDTConduit Pharmaceuticals Inc
$ 0.1228
(33.04%)
425.18M
AKTSAkoustis Technologies Inc
$ 0.0979
(12.40%)
165.19M
NVDANVIDIA Corporation
$ 144.86
(-0.71%)
140.13M
WORXSCWorx Corporation
$ 2.24
(128.57%)
86.64M
ELABElevai Labs Inc
$ 0.02035
(-4.91%)
77.43M

Discussion

View Full Feed
CrossFireTrader CrossFireTrader 1 minute ago
Me
GDVM
PROPHET-of-PROFITS PROPHET-of-PROFITS 1 minute ago
you were right about bleg and i was wrong.
BLEG
ColdDarkHole ColdDarkHole 1 minute ago
Should just remove that reddit page anyway. Its not doing anything but stirring up the natives. I would confidently say that any shares purchased based on that info were less than 1% of retail and not single cent was loaned based on it. Wish there was something to attract real money. That reddit
NB
HGilS HGilS 1 minute ago
CC: We are in a position that is very attractive for a pharmaceutical company with consistent profits, steady growth and low debt, and we are in a great position, a strong position for merger and acquisition, if the price is right, or a move up to NASDAQ.
ELTP
MoneyMan MoneyMan 1 minute ago
I see where company mentions meeting at Mara Lago in December
https://x.com/PsyKeyworld/status/1854221211464867967
CEOS
Trooperstocks Trooperstocks 2 minutes ago
$GRLF Green Leaf Innovations, Inc. Achieves Over 2,200% Revenue Growth Year-Over-Year https://finance.yahoo.com/news/green-leaf-innovations-inc-achieves-130000444.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr @otcgrlf
GRLF
02opida 02opida 2 minutes ago
Barchart is good Al :)
AITX
parrishilton parrishilton 2 minutes ago
.002 on the way first. The first CE removal pump went down now the dump is over it falls back to 002 then another CE could definitely possibly be in the works with all the lawsuits and shenanigans. That's why they wanted to go to arbitration to keep it out of FINRAS jurisdiction. You can't pay off c
CYBL
Bountiful_Harvest Bountiful_Harvest 2 minutes ago
Yeah, some of these premiums are ridiculous. I was wanting to buy 2025 $MSTR puts, but their premiums are insanely high!

I believe the silver lining with these all-time highs are the discounted puts (on $NVDA, the others are crazy high). I feel the 2025s allow time for things to unrav
MSTR NVDA SMCI
burner67 burner67 2 minutes ago
As you can tell, I put a lot of research into this. Thanks for noticing and I really appreciate your kind reply
BEGI
Trooperstocks Trooperstocks 2 minutes ago
$GRLF .0002's up! Green Leaf Innovations, Inc. Achieves Over 2,200% Revenue Growth Year-Over-Year https://finance.yahoo.com/news/green-leaf-innovations-inc-achieves-130000444.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr @otcgrlf
GRLF
snow snow 2 minutes ago
Sparty Your weakness is that you seem unable to understand the logical implications of what you write.
HERB
PROPHET-of-PROFITS PROPHET-of-PROFITS 2 minutes ago
did you notice that once the ss maxed out he decided to step back? knew when he stepped back he was only doing what he was doing to help his boys sell those shares. he called those kgkg insiders muppets when oswald was the puppet for the muppets lolol
BLEG
02opida 02opida 2 minutes ago
Get em now JustJack :)
AITX
Since 2012 Since 2012 3 minutes ago
Yet, here you are on a penny stock message board crying over a penny or two, impressive FF
CYDY
Zardiw Zardiw 3 minutes ago
Great......I'm under review on twitter........lol.......freedom of speech my ass........

ICC just issued arrest warrants for netanyahu.......but you can't say anything bad about israel...........lol

If more people only knew what total monsters israelis are.......The AB
Slojab Slojab 3 minutes ago
I'm curious as to what Dr. Aditya Ganguli has done in the past year to deserve being given 350,000,000 shares of stock, which was worth nearly $3,500,000 at the time of issuance and still worth nearly $3M today. Does he have to successfully complete an acquisition to be able to sell the stock? The n
AHIX
BigBadWolf BigBadWolf 3 minutes ago
$ASIInvestors https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175416305
as of the time of this post still Pink Current Information
ASIINVESTO
Govwhite Govwhite 3 minutes ago
Seems like stock force could see OPKO's sales. Is there a way to see if the promotion that started yesterday is yielding anything as far as increased sales? Or is it too early? 
NXPL
ducci1 ducci1 3 minutes ago
Sold 585P .74! 50% + Take it !
SPY
mascale mascale 3 minutes ago
Zero legal consultation noted in Jack_Herer post about Franco Nevada, or any link or reference regarding details: Versus Worldwide Google AI, public information.

So any notices that HIRU has a lawful basis example of its intentions on which to rely, plus likely extensive legal couns
HIRU
jimr1717 jimr1717 3 minutes ago
“Paid Bashers”, Marc needs more Marks like you and the Korean Hedge Funds that are short 5.5 Trillion shares EGOmike.

~~~No One Is Fooled~~~

~~~~~No One~~~~~
IFUS
duelittle2 duelittle2 3 minutes ago
In July 2025, Pink Current will become OTCID – a Basic Reporting Market for companies that meet a minimal current information standard and provide management certifications. Issuers that do not provide updated information will shift to the Pink Limited Market or to the Expert Market.

CNNA
diamondguru-one diamondguru-one 4 minutes ago
U's will using a different instrument IMO

what are u thinkin sunshine ?????
COOP

Your Recent History

NASDAQ
LUNG
Pulmonx
FTSE
4GUS
FTSE 4Good USA
NASDAQ
PENG
Pengiun Solutions
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved